Biobanking strategy and sample preprocessing for integrative
research in monoclonal gammopathies

J 2017

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies

SEVCIKOVA, Tereza, Katerina GROWKOVA, Zuzana CHYRA, Jana FILIPOVA, P. VRUBLOVA et. al.

Základní údaje

Originální název

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies

Autoři

SEVCIKOVA, Tereza (203 Česká republika), Katerina GROWKOVA (203 Česká republika), Zuzana CHYRA (203 Česká republika, domácí), Jana FILIPOVA (203 Česká republika), P. VRUBLOVA (203 Česká republika), Tomas JELINEK (203 Česká republika), Z. KORISTEK (203 Česká republika), F. KRYUKOV (203 Česká republika), Elena Vladimirovna KRYUKOVA (203 Česká republika, garant, domácí) a Roman HÁJEK (203 Česká republika)

Vydání

Journal of clinical pathology, London, BMJ Publishing Group, 2017, 0021-9746

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30109 Pathology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Full Text

Impakt faktor

Impact factor: 2.894

Kód RIV

RIV/00216224:14110/17:00100122

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1136/jclinpath-2017-204329

UT WoS

000411180200006

Klíčová slova anglicky

monoclonal gammopathies; MULTIPLE-MYELOMA; BONE-MARROW; PLASMA-CELLS; CRITERIA; DISEASE; RNA

Štítky

NZ, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 2. 1. 2020 16:21, Mgr. Marie Šípková, DiS.

Anotace

V originále

Aims Some types of monoclonal gammopathies are typified by a very limited availability of aberrant cells. Modern research use high throughput technologies and an integrated approach for detailed characterisation of abnormal cells. This strategy requires relatively high amounts of starting material which cannot be obtained from every diagnosis without causing inconvenience to the patient. The aim of this methodological paper is to reflect our long experience with laboratory work and describe the best protocols for sample collection, sorting and further preprocessing in terms of the available number of cells and intended downstream application in monoclonal gammopathies research. Potential pitfalls are also discussed. Methods Comparison and optimisation of freezing and sorting protocols for plasma cells in monoclonal gammopathies, followed by testing of various nucleic acid isolation and amplification techniques to establish a guideline for sample processing in haemato-oncology research. Results We show the average numbers of aberrant cells that can be obtained from various monoclonal gammopathies (monoclonal gammopathy of undetermined significance/light chain amyloidosis/multiple myeloma (MM)/MM circulating plasma cells/minimal residual disease MM-10 123/22 846/305 501/68 641/4000 aberrant plasma cells of 48/30/10/16/37x106 bone marrow mononuclear cells) and the expected yield of nucleic acids provided from multiple isolation kits (DNA/RNA yield from 1 to 200x10(3) cells was 2.14-427/0.12-123 ng). Conclusions Tested kits for parallel isolation deliver outputs comparable with kits specialised for just one type of molecule. We also present our positive experience with the whole genome amplification method, which can serve as a very powerful tool to gain complex information from a very small cell population.

Citovat

SEVCIKOVA, Tereza, Katerina GROWKOVA, Zuzana CHYRA, Jana FILIPOVA, P. VRUBLOVA, Tomas JELINEK, Z. KORISTEK, F. KRYUKOV, Elena Vladimirovna KRYUKOVA a Roman HÁJEK. Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies. Journal of clinical pathology. London: BMJ Publishing Group, 2017, roč. 70, č. 10, s. 847-853. ISSN 0021-9746. Dostupné z: https://dx.doi.org/10.1136/jclinpath-2017-204329.

@article{1409448,
   author = {Sevcikova, Tereza and Growkova, Katerina and Chyra, Zuzana and Filipova, Jana and Vrublova, P. and Jelinek, Tomas and Koristek, Z. and Kryukov, F. and Kryukova, Elena Vladimirovna and Hájek, Roman},
   article_location = {London},
   article_number = {10},
   doi = {http://dx.doi.org/10.1136/jclinpath-2017-204329},
   keywords = {monoclonal gammopathies; MULTIPLE-MYELOMA; BONE-MARROW; PLASMA-CELLS; CRITERIA; DISEASE; RNA},
   language = {eng},
   issn = {0021-9746},
   journal = {Journal of clinical pathology},
   note = {Doplnit podíly spolupracovišť!},
   title = {Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749344/pdf/jclinpath-2017-204329.pdf},
   volume = {70},
   year = {2017}
}

TY  - JOUR
ID  - 1409448
AU  - Sevcikova, Tereza - Growkova, Katerina - Chyra, Zuzana - Filipova, Jana - Vrublova, P. - Jelinek, Tomas - Koristek, Z. - Kryukov, F. - Kryukova, Elena Vladimirovna - Hájek, Roman
PY  - 2017
TI  - Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies
JF  - Journal of clinical pathology
VL  - 70
IS  - 10
SP  - 847-853
EP  - 847-853
PB  - BMJ Publishing Group
SN  - 00219746
N1  - Doplnit podíly spolupracovišť!
KW  - monoclonal gammopathies
KW  - MULTIPLE-MYELOMA
KW  - BONE-MARROW
KW  - PLASMA-CELLS
KW  - CRITERIA
KW  - DISEASE
KW  - RNA
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749344/pdf/jclinpath-2017-204329.pdf
L2  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749344/pdf/jclinpath-2017-204329.pdf
N2  - Aims Some types of monoclonal gammopathies are typified by a very limited availability of aberrant cells. Modern research use high throughput technologies and an integrated approach for detailed characterisation of abnormal cells. This strategy requires relatively high amounts of starting material which cannot be obtained from every diagnosis without causing inconvenience to the patient. The aim of this methodological paper is to reflect our long experience with laboratory work and describe the best protocols for sample collection, sorting and further preprocessing in terms of the available number of cells and intended downstream application in monoclonal gammopathies research. Potential pitfalls are also discussed. Methods Comparison and optimisation of freezing and sorting protocols for plasma cells in monoclonal gammopathies, followed by testing of various nucleic acid isolation and amplification techniques to establish a guideline for sample processing in haemato-oncology research. Results We show the average numbers of aberrant cells that can be obtained from various monoclonal gammopathies (monoclonal gammopathy of undetermined significance/light chain amyloidosis/multiple myeloma (MM)/MM circulating plasma cells/minimal residual disease MM-10 123/22 846/305 501/68 641/4000 aberrant plasma cells of 48/30/10/16/37x106 bone marrow mononuclear cells) and the expected yield of nucleic acids provided from multiple isolation kits (DNA/RNA yield from 1 to 200x10(3) cells was 2.14-427/0.12-123 ng). Conclusions Tested kits for parallel isolation deliver outputs comparable with kits specialised for just one type of molecule. We also present our positive experience with the whole genome amplification method, which can serve as a very powerful tool to gain complex information from a very small cell population.
ER  -

SEVCIKOVA, Tereza, Katerina GROWKOVA, Zuzana CHYRA, Jana FILIPOVA, P. VRUBLOVA, Tomas JELINEK, Z. KORISTEK, F. KRYUKOV, Elena Vladimirovna KRYUKOVA a Roman HÁJEK. Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies. \textit{Journal of clinical pathology}. London: BMJ Publishing Group, 2017, roč.~70, č.~10, s.~847-853. ISSN~0021-9746. Dostupné z: https://dx.doi.org/10.1136/jclinpath-2017-204329.

Podrobný výpis o publikaci